Asking price
£600,000,000GBP
A 60+ year family-owned international manufacturer of high-performance films and sustainable packaging solutions serving the food, medical, and non-food industries across 70+ countries. The business operates nine production sites in Europe and North America with approximately 1,755 employees and generates over €500 million in annual revenue.
Core revenue streams include coextruded multi-layer films (both hard and soft), laminated film structures, printed films (flexographic, gravure, and digital), and prefabricated pouches and bags. The business operates across four divisions: (1) Food packaging — lid films, thermoforming films, flow-wrap films, and stand-up pouches for meat, dairy, cheese, snacks, coffee, and convenience categories; (2) Medical packaging — sterile barrier solutions and cleanroom-produced films for medical device and pharmaceutical applications; (3) Non-food packaging — functional films for industrial and technical products; and (4) Custom compounding — specialized polymer compounds tailored to customer specifications. Production volume exceeds 724 million m² of film annually, with over half printed and laminated in-house. Key product lines include recyclable mono-material Pure-Line films, high-performance CarbonLite films, and sterile MedGuard packaging systems.
The business serves over 70 countries through 23 sales offices worldwide, with the largest customer segments in European meat and dairy packaging, followed by medical/pharmaceutical packaging and non-food industrial applications. Customers range from long-established family enterprises to global brand-name manufacturers and international conglomerates. The European flexible packaging market is valued at over €20 billion and growing, driven by sustainability regulations (EU PPWR), demand for recyclable mono-materials, and increasing food safety standards. The company holds an EcoVadis Platinum rating and has been named an Innovation Champion for four consecutive years. Revenue is well-diversified across geographies and end markets, with recurring B2B contracts underpinning stable demand.
The business employs approximately 1,755 people across ten production sites in Germany, France, Poland, Switzerland, the Netherlands, and the United States (via strategic partnership). Core competencies include cast and blown film coextrusion, laminating, flexo/gravure/digital printing, slitting, and pouch/bag converting. High vertical integration extends from custom compounding through extrusion, printing, laminating, and converting to recycling — enabling closed-loop material cycles. Operations run under cleanroom conditions at the medical division. The founding family remains actively involved in management, with a second-generation managing partner and a third-generation member recently appointed to lead a key business unit. The company also holds ISO certifications and SBTi-validated climate targets.
Near-term: (1) Regulatory tailwinds — EU Packaging and Packaging Waste Regulation (PPWR) mandates recyclable packaging by 2030, directly benefiting the company's Pure-Line mono-material portfolio; (2) Medical packaging expansion — growing demand for sterile barrier solutions in pharma and med-tech, supported by the MedGuard platform; (3) North American growth — the strategic partnership with a US converter provides a production and distribution foothold in the world's second-largest flexible packaging market. Medium-term: (4) Bio-based compounds — entering a fast-growing niche as brands seek fossil-free alternatives; (5) Chemical recycling — the company already regranulates 6,500+ tonnes of production waste annually, positioning it to offer certified circular feedstock. Longer-term: (6) Geographic expansion into Asia-Pacific and further US capacity; (7) Digital printing adoption — reducing minimum order sizes could unlock long-tail SME customers.
Similar deals buyers are exploring right now.
Asking price
£600,000,000GBP
Sign up free to contact the seller
